Skip to content

Clinical trials

Phase 1/2 Cystic Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 1/2 Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20033
20041
20061
20072
20084
20101
20113
20123
20133
20141
20152
20163
20172
20189
20191
20202
20211
20222
20231
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated6
Unknown status3
Withdrawn2
Suspended1
Recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Jewish Health3
Vertex Pharmaceuticals Incorporated3
Boehringer Ingelheim2
Children's Hospital of Philadelphia2
Flatley Discovery Lab LLC2
Insmed Incorporated2
InterMune2
Joseph Zabner2
Novartis Pharmaceuticals2
Proteostasis Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis54
Pseudomonas Infections7
Respiratory Tract Infections3
Respiratory Aspiration2
Aspergillosis, Allergic Bronchopulmonary1
Asthma1
Bronchiolitis Obliterans Syndrome1
Diabetes Mellitus, Type 11
Digestive System Diseases1
Exocrine Pancreatic Insufficiency1

Trials

Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.